Search

Desmoid tumors (DTs) are rare fibroblastic proliferations, characterized by infiltrative growth and a propensity for local recurrence. Traditional strategies such as surgery, radiotherapy, and chemotherapy are the mainstays of treatment, each with its limitations and associated risks. The trend in DT management leans toward a "wait-and-see" strategy, emphasizing active surveillance supported by continuous MRI monitoring. This approach acknowledges the unpredictable nature of the disease, and a multidisciplinary management of DT requires a nuanced approach, integrating traditional therapies with emerging interventional techniques. This review highlights the emerging role of minimally invasive interventional radiological technologies and discusses interventional radiology techniques, including chemical, radiofrequency, microwave, cryoablation, and high-intensity focused ultrasound ablations as well as transarterial embolization. [ABSTRACT FROM AUTHOR]

Introduction: Mycotic aortic aneurysm (MAA) is a life-threatening condition. Endovascular repair (EVAR) of aortic aneurysms has been found to be a safe and effective alternative to open repair. We aimed to present the short- to medium-term outcomes for EVAR of MAA in our cohort.Methods: We conducted a retrospective study of 23 consecutive patients with MAA who underwent EVAR in our hospital from January 2008 to July 2017.Results: The mean age of our study population was 62 years. The mean aneurysmal size was 3.2 cm. Abdominal MAA (n = 16, 70%) were the most common, followed by thoracic MAA (n = 4, 17%). There was no 30-day mortality in our cohort. Endoleak (Types 1, 3, 4) was detected in 3 (13%) cases. At the one-month surveillance computed tomography aortogram, all patients had a reduction in aneurysmal size and 5 (22%) had complete aneurysmal sac resolution. 7 (30%) patients had sac resolution at six months and 8 (35%) patients at 12 months. Overall survival was 91%, 80% and 61% at one, 12 and 60 months, respectively.Conclusion: EVAR is a feasible and durable method for the repair of MAA, with a five-year overall survival of 61%. All patients in our study had a reduction in aneurysmal size at one month, with 65% having complete aneurysmal sac resolution by 12 months. [ABSTRACT FROM AUTHOR]

Objective: Current literature regarding iliofemoral intervention and stenting is mostly based on Western populations. We present our experience of iliofemoral stenting for chronic venous disease within a South‐East Asian population. Methods: This is a single‐centre retrospective review of a prospectively collected registry. Seventy‐one patients with 105 limbs underwent iliac vein IVUS and stenting between 2016 and 2019. All patients underwent pre‐procedure ultrasound venous scan and MRI venogram. Pre‐ and post‐operative CEAP classification, Villalta score and Venous Clinical Severity Score (VCSS), technical results, stent patency rates and complication rates are documented. Results: Seventy‐six per cent of the cases are non‐thrombotic iliac vein lesion, and 68% of patients have C4 to C6 disease. Ten percentage of patients had acute thrombosis on presentation. There was 100% technical success. A 6‐ and 7‐point reduction in the mean VCSS and Villalta score, respectively, were noted post‐stenting (baseline of 10 points and P < 0.001 in both categories). Post‐stenting ulcer healing rate was 91% at 6 and 12 months. One‐year ulcer recurrence and cellulites recurrence were at 8% and 7%, respectively. One unplanned 30‐day readmission (not related to procedure) and no 30‐day mortality were noted. Bleeding complication from anticoagulation was 3%. There was 10% in‐stent non‐flow limiting stenosis on surveillance. One‐year primary patency was 91%, and secondary patency was 100%. Conclusion: Within our series, iliofemoral stenting has 100% technical success, with statistically significant reduction in VCSS and Villalta score, good wound healing rates, low ulcer and cellulites recurrence and good primary and secondary patency rates at 1 year. [ABSTRACT FROM AUTHOR]

Introduction: Transradial artery access (TRA) is an established technique employed by interventional cardiologists for diagnostic and therapeutic coronary interventions. The use of TRA has gained increasing traction amongst interventional radiologists in recent years. In transradial, non-coronary interventions, the aorta has to be traversed. With increasing age, atherosclerotic changes in the aorta posed a theoretical risk of catheter-related emboli. Currently, there is limited literature available on the cerebral ischaemic complication rates in transradial non-coronary interventions.Methods: Between November 2015 and December 2017, 150 transradial non-coronary interventions were performed on 95 patients. Intra-procedural, in-hospital, 30-day and 6-month complications (ischaemic stroke, transient ischaemic attack and death, and minor complications, such as puncture site haematoma, pseudoaneurysm, thrombosis, dissection and perforation) were compared between the two age groups (≤65 and >65 years old).Results: The patients were predominantly male (87.0%) with age ≤65 (N = 69; 46.0%) and age >65 (N = 81; 54.0%). There were no ischaemic strokes at all time points in both groups, except for one case of ischaemic stroke at 6 months in the age ≤65 group(1.4% vs. 0.0%; P = 0.462). On multivariable analysis, age >65 was associated with lower in-hospital death rates (OR 0.251; 95% CI 0.013-3.09), at 30 days (OR 0.608; 95% CI 0.77-4.805) and at 6 months (OR 0.514; 95% CI 0.169-1.558) with no deaths intra-procedurally in both groups. Minor complications include puncture site grade I haematoma formation (2.9% vs. 2.5%; P = 0.999) and pseudoaneurysm (2.9% vs. 0.0%; P = 0.210). In our study, the overall major and minor complications rates are low and no statistically significant difference exists between the two groups.Conclusion: Transradial non-coronary interventions are safe in elderly patients, who are likely to have more atherosclerotic disease of the aorta. Of note, no complication of ischaemic strokes within 30 days of the procedure is documented in all patients. [ABSTRACT FROM AUTHOR]

Introduction: Mycotic aortic aneurysm (MAA) is a life-threatening condition. Endovascular repair (EVAR) of aortic aneurysms has been found to be a safe and effective alternative to open repair. We aimed to present the short- to medium-term outcomes for EVAR of MAA in our cohort., Methods: We conducted a retrospective study of 23 consecutive patients with MAA who underwent EVAR in our hospital from January 2008 to July 2017., Results: The mean age of our study population was 62 years. The mean aneurysmal size was 3.2 cm. Abdominal MAAs (n = 16, 70%) were the most common, followed by thoracic MAAs (n = 4, 17%). There was no 30-day mortality in our cohort. Endoleak (Types 1, 3, 4) was detected in 3 (13%) cases. At the one-month surveillance computed tomography aortogram, all patients had a reduction in aneurysmal size and 5 (22%) had complete aneurysmal sac resolution. 7 (30%) patients had sac resolution at six months and 8 (35%) patients, at 12 months. The overall survival was 91%, 80% and 61% at one, 12 and 60 months, respectively., Conclusion: EVAR is a feasible and durable method for the repair of MAA, with a five-year overall survival of 61%. All patients in our study had a reduction in aneurysmal size at one month, with 65% having complete aneurysmal sac resolution by 12 months., (Copyright: © Singapore Medical Association.)